General Fusion director reports option and earnout stakes
Harrison Norman, a director of General Fusion Group Ltd., filed an initial statement of beneficial ownership showing multiple stock option and earnout option holdings.
Rhea-AI Filing Summary
Harrison Norman, a director of General Fusion Group Ltd., filed an initial statement of beneficial ownership showing multiple stock option and earnout option holdings. Positions include options on 55,804 common shares at $0.5300 and 29,074 shares at $8.9500, plus earnout options on 21,243 earnout shares at $0.0100. Earnout Shares convert into common shares only if the volume weighted average price reaches $15.00, $20.00 and $25.00, respectively, on or before July 10, 2031.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (right to buy) F1 | -- | -- | -- |
| holding | Stock Option (right to buy) F2 | -- | -- | -- |
| holding | Stock Option (right to buy) F3 | -- | -- | -- |
| holding | Stock Option (right to buy) F3 | -- | -- | -- |
| holding | Stock Option (right to buy) F3 | -- | -- | -- |
| holding | Earnout Options (right to buy) F1, F4 | -- | -- | -- |
| holding | Earnout Options (right to buy) F2, F4 | -- | -- | -- |
| holding | Earnout Options (right to buy) F3, F4 | -- | -- | -- |
Footnotes (4)
- F1. These options vest in three substantially equal installments on the first, second and third anniversaries of the original date of grant by General Fusion Inc. (the "Legacy Company"), or in the case of Earnout Options, the first, second and third anniversaries of the original date of grant of the associated option award. All underlying shares that vested prior to the closing of the Legacy Company's business combination with Spring Valley Acquisition Corp. III (the "Business Combination") remained vested following their exchange for options of General Fusion Group Ltd. (the "Company"), and the Earnout Options associated with each option award retained the vesting history of the associated option award.
- F2. These options vested as to 25% of the underlying shares on the first anniversary of the original date of grant by the Legacy Company, or in the case of Earnout Options, the first anniversary of the original date of grant of the associated option award, with the remaining shares vesting in 12 substantially equal quarterly installments thereafter. All underlying shares that vested prior to the closing of the Business Combination remained vested following their exchange for options of the Company, and the Earnout Options associated with each option award retained the vesting history of the associated option award.
- F3. These options vest as to 25% of the underlying shares on the first anniversary of the original date of grant by the Legacy Company, or in the case of Earnout Options, the first anniversary of the original date of grant of the associated option award, with the remaining shares vesting in 12 substantially equal quarterly installments thereafter.
- F4. Earnout Shares, including the Earnout Shares underlying the Earnout Options, consist of a substantially equal number of Class A Earnout Shares, Class B Earnout Shares, and Class C Earnout Shares, which will automatically convert into common shares of the Company if, on or before July 10, 2031, the volume weighted average price of the Company's common shares equals or exceeds each of $15.00, $20.00 and $25.00, respectively, for any 20 trading days within any period of 30 consecutive trading days.
Key Figures
Key Terms
Earnout Options financial
volume weighted average price financial
Business Combination financial
substantially equal quarterly installments financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 3 filing for GFUZ report about Harrison Norman?
What are the terms of the higher-priced stock options reported for GFUZ?
How did the GFUZ business combination affect Harrison Norman’s option grants?
AI-generated analysis. How Rhea-AI works. Not financial advice.